Concourse Financial Group Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-806
Closed -$143K 2348
2020
Q1
$143K Buy
806
+373
+86% +$70.2K 0.02% 555
2019
Q4
$83K Buy
433
+98
+29% +$17.7K 0.01% 770
2019
Q3
$56K Sell
335
-399
-54% -$65K 0.01% 588
2019
Q2
$123K Buy
734
+94
+15% +$13K 0.01% 611
2019
Q1
$93K Sell
640
-286
-31% -$41.5K 0.01% 704
2018
Q4
$123K Buy
926
+329
+55% +$53.9K 0.01% 582
2018
Q3
$114K Buy
+597
New +$110K 0.03% 399

Other funds holding AGN

Concourse Financial Group Securities's AGN Position: Q2 2020 in Review

Concourse Financial Group Securities sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 806 shares — an estimated $143K sold.

Concourse Financial Group Securities first reported a position in AGN in Q3 2018 and held it in 7 quarters. The position peaked at $143K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Concourse Financial Group Securities reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Concourse Financial Group Securities sold 806 Allergan plc shares in Q2 2020, an estimated $143K.
  • Concourse Financial Group Securities first reported a position in Allergan plc in Q3 2018 and held it in 7 quarters.
  • Concourse Financial Group Securities's Allergan plc position peaked at $143K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Concourse Financial Group Securities's 13F filing for Q2 2020, filed 13 Aug 2020.